CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 60 enrolled
Drug / intervention
Aged garlic powder +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01402102
NCT01402102Phase 3Completed
CompareCT.gov

Efficacy and Safety of Aged Garlic Powder on Lipids

Chonbuk National University Hospital·interventional·Posted Jul 26, 2011·Updated Oct 12, 2012

In Brief

A Phase 3 clinical trial evaluating Aged garlic powder and Placebo powder for Hyperlipidemia. Completed, enrolled 60 participants across 1 site.

Detailed Summary

We performed a double-blind parallel study in a group of mildly hypercholesterolemic subjects who were given aged garlic powder over a period of 12 weeks. We measured serum lipids, including total cholesterol, low-density-lipoprotein (LDL) and high-density-lipoprotein (HDL) cholesterol, and triglycerides, and monitored their blood pressure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperlipidemia
CountriesSouth Korea
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 26, 2011
Enrollment StartJul 1, 2010
Primary CompletionMar 1, 2011
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.9 years ago

Interventions

Aged garlic powderdietary

Aged garlic powder(6.0g/day)

Placebo powderdietary

Placebo powder(6.0g/day)